Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19522171 | 1.00 | TSHR (0.33) | TSHRTDP1LMNAL3MBTL1 | |
| SCHEMBL16924994 | 0.91 | TSHR (0.33) | TSHRTDP1LMNAL3MBTL1 | |
| SCHEMBL2303494 | 0.89 | TSHR (0.41) | TSHRTDP1LMNAL3MBTL1 | |
| SCHEMBL20893308 | 0.78 | TSHR (0.45) | TSHRTDP1LMNA | |
| SCHEMBL19592300 | 0.77 | TDP1 (0.35) | TSHRTDP1LMNAL3MBTL1 | |
| SCHEMBL19277005 | 0.77 | TDP1 (0.35) | TSHRTDP1LMNAL3MBTL1 | |
| SCHEMBL18934170 | 0.77 | TDP1 (0.35) | TSHRTDP1LMNAL3MBTL1 | |
| SCHEMBL15966302 | 0.77 | TDP1 (0.35) | TSHRTDP1LMNAL3MBTL1 | |
| SCHEMBL16079082 | 0.77 | TDP1 (0.35) | TSHRTDP1LMNAL3MBTL1 | |
| SCHEMBL20143360 | 0.77 | TDP1 (0.35) | TSHRTDP1LMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10660974-B2 | Chemiluminescent probes for diagnostics and in vivo imaging | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2020-05-26 | — | — | US | disclosed |
| US-20190290787-A1 | CHEMILUMINESCENT PROBES FOR DIAGNOSTICS AND IN VIVO IMAGING | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10660974-B2 | Chemiluminescent probes for diagnostics and in vivo imaging | DAXX, DCAF15, DCAF1 | TSHR 1960/4885TDP1 1151/4885LMNA 669/4885 |
| US-20190290787-A1 | CHEMILUMINESCENT PROBES FOR DIAGNOSTICS AND IN VIVO IMAGING | DAXX, DCAF15, DCAF1 | TSHR 1960/4885TDP1 1151/4885LMNA 669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.